Johnson and Johnson Merck Consumer Pharmaceuticals

Bookmark

Add to MyYahoo RSS

Johnson and Johnson Merck Consumer Pharmaceuticals News

News on Johnson and Johnson Merck Consumer Pharmaceuticals continually updated from thousands of sources around the net.

44 min ago | Adrants

Without Admitting Their Products Where Ever Bad, Johnson's Touts Reformulated Baby Products

Without admitting the ingredients formaldehyde and 1,4-dioxane, present in 100 of its baby products, Johnson's Baby, which earlier this year began introducing reformulated products, is out with a delightfully fuzzy, feel good campaign touting the removal of those ingredients.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Life, Hobbies, Origami

3 hrs ago | Sys-Con Media

Milestone Scientific Appoints Senior Healthcare Industry Executive...

Milestone Scientific Inc. , a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced the appointment of Steven F. Robins to the position of Marketing Consultant.

Comment?

Related Topix: Marketing, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

8 hrs ago | Reuters

UPDATE 1-U.S. Senate panel to look into price setting for contact lenses

Moves by three of the four major U.S. contact lens makers to set price floors for many of their products, preventing low-cost retailers from discounting the expensive devices, have drawn scrutiny from lawmakers.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Bausch and Lomb, Medical Equipment, VisionCare Ophthalmic Technologies, Startups, OrthoClinical Diagnostics

Tue Jul 29, 2014

Beet.TV

JWT's Branded Content Approach Starts with Participation

Branded content is not an "if" for marketers; it's a must-have, says Eric Weisberg, Executive Creative Director at JWT , in an interview with Beet.TV.

Comment?

Related Topix: Native Advertising, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Family, Kids

ZDNet

IBM board adds Johnson & Johnson CEO, former Royal Dutch Shell CEO

Closing out a month that included a landmark deal with Apple, IBM is boosting its board of directors with two new additions who are seasoned chief executives.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Mon Jul 28, 2014

Forbes.com

One Put, One Call Option To Know About for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Sun Jul 27, 2014

The Telegraph

High valuations put on older generics

Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.

Comment?

Related Topix: Biotech, Dr Reddys Laboratories, Johnson & Johnson, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Fri Jul 25, 2014

The Washington Post

Puma's Auerbach Gained on Pfizer's Early Retreat on Breast Drug

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

Comment?

Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Science / Technology, Health, Breast Cancer, Healthcare Law, Law

CNN

Xarelto Side Effects Lawsuit News: New Lawsuit Alleges Xarelto...

Close to 10 Xarelto side effects lawsuits have been filed in the United States against Janssen Pharmaceuticals, a division of Johnson & Johnson and Germany-based Bayer AG over its blood-thinning medication.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Reuters

Europe backs new leukaemia drugs from J&J and Gilead

Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Food, J and J Snack Foods, Johnson & Johnson, Johnson and Johnson

Thu Jul 24, 2014

Heavy Duty Trucking

Baxter Healthcare's Fleet Manager Receives 2014 Fleet Safety Award

Fleet Safety Conference Chair Mike Antich, 2014 Fleet Safety Award Honoree Kristin O'Driscoll of Baxter Healthcare, and Pam Sederholm, executive director or AALA.

Comment?

Related Topix: Schaumburg, IL, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Truckers

GigaOM

Johnson & Johnson partners with Organovo to consider 3D-printing living tissue

The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

The New Zealand Herald

What's best for baby?

Sharon Dowling, research and development manager for leading company Johnson & Johnson , shares her advice.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 23, 2014

Mother Jones

For Lower Back Pain, You Can Skip the Tylenol

About two-thirds of adults have lower back pain at some point in their lives, and most are told to take acetaminophen, sold under brand names like Tylenol, Anacin and Panadol.

Comment?

Related Topix: Tylenol, Tempra, Acetaminophen (generic), Medicine, Health, Pain, Back Pain, Johnson & Johnson, Biotech, Johnson and Johnson, Healthcare Industry

The Campbell Reporter

Puma Biotech soars on positive breast cancer drug results

Puma Biotechnology' stock soared Wednesday after the company reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.

Comment?

Related Topix: Medicine, Cancer, Health, Breast Cancer, Biotech, Science / Technology, Healthcare Law, Law, Johnson & Johnson, Healthcare Industry

The Motley Fool

Why the Market Is Wrong About Intuitive Surgical Stock

Strong shipments of the Xi system are encouraging, as was the better-than-expected procedure growth, but utilization is still challenging and Revenue fell more than 11% this quarter, but was still about 2% better than the sell-side expected.

Comment?

Related Topix: Startups, Intuitive Surgical, Science / Technology, Robots, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Puma's experimental drug neratinib delayed the return of cancer in a large trial of women with early-stage breast cancer .

Comment?

Related Topix: Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson, Healthcare Industry, Business News

Tue Jul 22, 2014

The Motley Fool

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Here are three quotes from the call and some commentary about why they're so important.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, DePuy Orthopaedics, Hospital Administration, St Peters Health Care Services

Business Journal

Johnson & Johnson board approved $5B stock buyback plan

Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••